News Feed Item

IntriCon Reports 2016 Fourth-Quarter Results

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter ended December 31, 2016.


  • Sales to IntriCon’s largest medical customer increased $1.0 million sequentially from the third quarter—sales to this customer in the 2017 first quarter are expected to be at record levels and continue to increase throughout the year;
  • The company’s value hearing health initiatives delivered year-over-year growth, with Hearing Help Express contributing $1.0 million in fourth-quarter revenue;
  • IntriCon sharpened its focus on the emerging value hearing health opportunity, exercising its option to acquire 100 percent of Hearing Help Express (HHE). Beginning in the quarter, HHE financial results have been consolidated into IntriCon’s financial statements; and;
  • The company found a buyer for its non-core cardiac diagnostic monitoring (CDM) business, which is now held for sale and classified as discontinued operations.

Financial Results
For the 2016 fourth quarter, the company reported net sales of $17.7 million, compared to $18.4 million in the prior-year period. The decline was primarily due to year-over-year revenue shifts from IntriCon’s largest customer. Net sales rose 14 percent sequentially from the 2016 third quarter and included a $1.0 million contribution from HHE. IntriCon posted a net loss attributable to shareholders of ($1,809,000), or ($0.27) per share, versus net income attributable to shareholders of $810,000, or $0.13 per diluted share, for the 2015 fourth quarter. The 2016 fourth-quarter loss included a loss from discontinued operations of ($1,014,000), or ($0.15) per share, of which $796,000, resulted from a non-cash, write down of assets related to the pending divestiture of the company’s CDM business.

“Fourth-quarter results reflect our efforts to right size and focus our business to take advantage of the emerging value hearing health opportunity while maximizing our core medical business,” said Mark S. Gorder, president and chief executive officer of IntriCon. “We made meaningful progress establishing a new direct-to-consumer distribution channel during the quarter and look forward to a strong first quarter and 2017 in both hearing health and medical.”

Gross profit margins were 25.9 percent compared to 29.3 percent in the prior-year fourth quarter. The decrease was primarily due to lower revenue.

Operating expenses for the fourth quarter were $5.0 million, compared to $4.2 million in the prior-year fourth quarter. The increase was largely due to the consolidation of HHE during the quarter.

Business Update
Sales in IntriCon’s medical business decreased 8 percent in the 2016 fourth quarter, primarily driven by timing shifts with IntriCon’s largest customer, Medtronic. The lower sales to Medtronic were expected as they manage the transition of their recently FDA-approved MiniMed 630G system. IntriCon began ramping up MiniMed 630G production in the fourth quarter which resulted in a $1.0 million sequential increase in Medtronic revenue from the 2016 third quarter.

The company believes it’s well-positioned with Medtronic, with 2017 first-quarter sales expected to be at record levels, and growth to continue throughout the year. In addition to the MiniMed 630G system, IntriCon is also designed into the MiniMed 670G system which was recently approved by the FDA, and is scheduled to be launched in the spring of 2017. The company is working on other revenue opportunities with Medtronic that could result in notable revenue gains in the second half of 2017.

Hearing health sales increased 4 percent from the prior-year fourth quarter, primarily stemming from a $1.0 million contribution from HHE. As previously announced, IntriCon acquired a 20 percent stake in DeKalb, Ill.-based HHE, a direct-to-consumer mail order hearing aid provider, in the fourth quarter of 2016. In January 2017, the company announced that it exercised its option to acquire the remaining 80 percent stake in HHE—the deal is expected to close in mid-2017.

Said Gorder, “Acquiring HHE gives IntriCon direct access to consumers and the emerging value-based hearing health care market. HHE offers a lower-priced alternative for consumers to purchase devices directly—circumventing layers of costs associated with the conventional hearing aid channel. We look forward to building on the HHE platform by leveraging our own technically advanced devices and making targeted investments in management, marketing and advertising—and ultimately incorporating an online component.”

Since taking its initial stake, IntriCon has made meaningful progress integrating and optimizing HHE. To date IntriCon has:

  • Streamlined management positions—generating nearly $300,000 in net annual cost savings;
  • Contracted a direct-to-consumer (DTC) leader to head operations;
  • Started to map out the introduction of IntriCon’s advanced digital hearing devices into HHE’s product line;
  • Transitioned all treasury controls to IntriCon corporate headquarters; and,
  • Leased a new HHE facility which is expected to drive operating efficiencies and better work management by merging two locations into one.

Continued Gorder, “Untreated hearing loss in the United States is a substantial problem, and high device costs have created significant barriers to access for most Americans. HHE offers a lower-priced alternative for consumers to purchase devices directly.”

According to Gorder, IntriCon’s near-term next steps for HHE are to:

  • Hire a DTC executive to manage HHE;
  • Enhance HHE’s sales and marketing capabilities and increase advertising, a tactic historically proven to drive sales; and,
  • Introduce IntriCon’s digital hearing aids and other technical advancements to HHE’s customer base.

The fourth-quarter hearing health gain also contained contributions by PC Werth, acquired by IntriCon UK to build a hearing health platform in England. In January 2017, IntriCon took steps to reduce PC Werth’s cost structure by $200,000 and refocus sales efforts into the National Health Service (NHS) clinics. IntriCon is currently working with the NHS for approval of a third device, the K940D, which will enhance IntriCon sales capabilities. The K940D, which is a traditional behind-the-ear device, is very appealing to the NHS because of its broad-fitting range and advanced features. Approval of the K940D is anticipated by the end of April.

In addition to HHE and PC Werth, IntriCon is focused on driving growth and creating efficiencies in its current value-based hearing healthcare initiatives. Domestically, IntriCon continues its work with earVenture, a joint venture with the Academy of Doctors of Audiology (ADA). Over 650 ADA members have registered to join the earVenture program. According to Gorder, audiologists have shown great interest in earVenture, but have been slow to adopt the new model.

IntriCon has taken steps to right-size earVenture, without compromising the ability to promote the business model. While the company does not view earVenture, near term, as a meaningful contributor to sales, it continues to provide valuable industry insights and has the potential for future value by connecting it to IntriCon’s emerging DTC channel.

Said Gorder, “Acknowledging the significant opportunity we have with HHE has prompted us to focus our efforts with the ADA and NHS. Over the last decade, we have invested in technology and low-cost manufacturing to design and build superior devices and fitting solutions to address the estimated $1 billion annual value hearing health market.”

In order to focus financial and operational resources on value hearing health and the growing DTC opportunity, IntriCon has made the strategic decision to divest its non-core CDM business. The company has found a buyer for the business, and the sale is expected to close in the first quarter of 2017.

Looking Ahead
Concluded Gorder, “2016 was transitional year for IntriCon as we made changes and investments to focus our business. We enter 2017 with the infrastructure in place to drive long-term growth, and we remain confident in the prospects of our medical business and look forward to the expected 2017 ramp up of Medtronic’s sales. Equally important, we’re excited about the opportunity that we created through thoughtful hard work and planning: a chance to deliver superior outcomes-based affordable hearing healthcare. We expect that capitalizing on this opportunity will lead to both a very bright future for IntriCon and to long-term growth in shareholder value. Based on information currently available, we anticipate 2017 first-quarter net sales to be $18.6 to $18.8 million and positive EPS from continuing operations. For the year, we anticipate revenue to range between $78 million and $80 million.”

Conference Call Today
As previously announced, the company will hold an investment community conference call today, Thursday, February 16, 2017, beginning at 4 p.m. CT. Mark Gorder, president and chief executive officer, and Scott Longval, chief financial officer, will review fourth-quarter performance and discuss the company’s strategies. To join the conference call, dial: 1-888-263-2744 and provide the conference ID number 9031214 to the operator. To access the replay, dial 1-888-203-1112 and enter passcode 9031214.

About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.

Forward-Looking Statements
Statements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and other factors are detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2015. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.

Consolidated Condensed Statement of Operations
(In Thousands, Except Per Share Amounts)
Three Months Ended Twelve Months Ended
December 31,     December 31, December 31,   December 31,
2016 2015 2016 2015





Sales, net $ 17,747 $ 18,435 $ 68,009 $ 68,527
Cost of sales   13,148     13,027     50,937     49,771  
Gross profit 4,599 5,408 17,072 18,756
Operating expenses:
Sales and marketing 1,343 1,134 4,700 3,733
General and administrative 2,583 1,931 9,154 7,013
Research and development 1,126 1,116 4,688 4,279
Restructuring charges   -     -     132     -  
Total operating expenses   5,052     4,181     18,674     15,025  
Operating income (loss) (453 ) 1,227 (1,602 ) 3,731
Interest expense (167 ) (82 ) (553 ) (369 )
Other income (expense)   (129 )   (278 )   (602 )   (261 )
Income (loss) from continuing operations before income taxes and discontinued operations (749 ) 867 (2,757 ) 3,101
Income tax (benefit) expense   97     (88 )   217     19  
Income (loss) before discontinued operations (846 ) 955 (2,974 ) 3,082
Loss from discontinued operations, net of income taxes (1,014 ) (256 ) (1,770 ) (965 )
Gain on sale of discontinued operations, net of income taxes   -     -     -     -  
Net Income (loss)   (1,860 )   699     (4,744 )   2,117  
Less: Loss allocated to non-controlling interest   (51 )   (111 )   (157 )   (111 )
Net Income (loss) attributable to shareholders $ (1,809 ) $ 810   $ (4,587 ) $ 2,228  
Basic income (loss) per share attributable to shareholders:
Continuing operations $ (0.12 ) $ 0.18 $ (0.43 ) $ 0.54
Discontinued operations   (0.15 )   (0.04 )   (0.27 )   (0.16 )
Net income (loss) per share: $ (0.27 ) $ 0.14   $ (0.71 ) $ 0.38  
Diluted income (loss) per share attributable to shareholders:
Continuing operations $ (0.12 ) $ 0.17 $ (0.43 ) $ 0.51
Discontinued operations   (0.15 )   (0.04 )   (0.27 )   (0.15 )
Net income (loss) per share: $ (0.27 ) $ 0.13   $ (0.71 ) $ 0.36  
Average shares outstanding:
Basic 6,805 5,977 6,497 5,907
Diluted 6,805 6,291 6,497 6,241
Consolidated Condensed Balance Sheets
(in thousands, except per share data)
December 31, December 31,




Current assets:
Cash $ 667 $ 367
Restricted cash 595 610
Accounts receivable, less allowance for doubtful accounts of $170 at December 31, 2016 and $135 at December 31, 2015 7,289 8,335
Inventories 12,343 13,635
Other current assets 957 856
Current assets of discontinued operations   123     1,086  
Total current assets 21,974 24,889
Machinery and equipment 40,152 38,426
Less: Accumulated depreciation   33,546     31,717  
Net machinery and equipment 6,606 6,709
Goodwill 10,555 9,551
Intangible Assets 2,920 -
Investment in partnerships 146 224
Other assets, net 1,557 480
Other assets of discontinued operations   -     33  
Total assets (a) $ 43,758   $ 41,886  
Current liabilities:
Current maturities of long-term debt $ 2,346 $ 1,908
Accounts payable 6,722 7,763
Accrued salaries, wages and commissions 2,413 2,466
Deferred gain - 55
Other accrued liabilities 1,914 1,279
Liabilities of discontinued operations   123     116  
Total current liabilities 13,518 13,587
Long-term debt, less current maturities 9,284 7,929
Other postretirement benefit obligations 501 542
Accrued pension liabilities 737 812
Other long-term liabilities   707     119  
Total liabilities (a) 24,747 22,989
Commitments and contingencies
Shareholders’ equity:
Common stock, $1.00 par value per share; 20,000 shares authorized; 6,820 and 5,981 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively 6,820 5,981
Additional paid-in capital 21,383 17,721
Accumulated deficit (8,633 ) (4,046 )
Accumulated other comprehensive loss   (1,014 )   (721 )
Total shareholders' equity 18,556 18,935
Non-controlling interest   455     (38 )
Total equity   19,011     18,897  
Total liabilities and equity $ 43,758   $ 41,886  
(a) Assets of HHE, the consolidated variable interest entity, that can only be used to settle obligations of HHE were $5,159 at December 31, 2016. Liabilities of HHE, for which creditors do not have recourse to the general credit of IntriCon were $3,833 at December 31, 2016.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at @ThingsExpo, Greg Gorman is the Director, IoT Developer Ecosystem, Watson IoT, will provide a short tutorial on Node-RED, a Node.js-based programming tool for wiring together hardware devices, APIs and online services in new and interesting ways. It provides a browser-based editor that makes it easy to wire together flows using a wide range of nodes in the palette that can be deployed to its runtime in a single-click. There is a large library of contributed nodes that help so...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Many organizations adopt DevOps to reduce cycle times and deliver software faster; some take on DevOps to drive higher quality and better end-user experience; others look to DevOps for a clearer line-of-sight to customers to drive better business impacts. In truth, these three foundations go together. In this power panel at @DevOpsSummit 21st Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, industry experts will discuss how leading organizations build application success from all...
Most of the time there is a lot of work involved to move to the cloud, and most of that isn't really related to AWS or Azure or Google Cloud. Before we talk about public cloud vendors and DevOps tools, there are usually several technical and non-technical challenges that are connected to it and that every company needs to solve to move to the cloud. In his session at 21st Cloud Expo, Stefano Bellasio, CEO and founder of Cloud Academy Inc., will discuss what the tools, disciplines, and cultural...
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
Agile has finally jumped the technology shark, expanding outside the software world. Enterprises are now increasingly adopting Agile practices across their organizations in order to successfully navigate the disruptive waters that threaten to drown them. In our quest for establishing change as a core competency in our organizations, this business-centric notion of Agile is an essential component of Agile Digital Transformation. In the years since the publication of the Agile Manifesto, the conn...
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, will introduce two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a mu...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
Trying to improve density, lower costs and run applications faster than before? Today, enterprises looking for a secure cloud strategy are increasingly turning to container-based Platform as a Service solutions for on-premises hosted DevOps. In her session at 21st Cloud Expo, Alise Cashman Spence, Offering Manager, Power Systems Cloud Solutions at IBM, will discuss the driving factors behind these cloud trends and how IBM customers are realizing exceptional performance, security and control for ...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In their Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, and Mark Lav...